| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.39美元,归母净利润6135.40万美元,同比去年增长-51.81%
|
| 2025-11-13 |
财报披露：
美东时间 2025-11-13 盘后发布财报
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益0.64美元,归母净利润2825.20万美元,同比去年增长-66.25%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益0.70美元,归母净利润3063.50万美元,同比去年增长-32.01%
|
| 2025-03-28 |
股东大会：
将于2025-04-30召开股东大会
会议内容 ▼▲
- 1.Presentation of the reports of the independent auditor and of the reports of the Board of Directors of the Company on the consolidated accounts for the financial year ended on December 31, 2024 and on the annual accounts of the Company for the financial year ended on December 31, 2024;
2.Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the financial year ended December 31, 2024;
3.Approval of the Company’s annual accounts under LUX GAAP as of and for the financial year ended December 31, 2024;
4.Allocation of results for the financial year ended December 31, 2024;
5.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2024;
6.Approval of the cash and share-based compensation payable to the non-executive members of the Board of Directors for the financial year ending on December 31, 2025;
7.Appointment of PricewaterhouseCoopers, Societe cooperative, as independent auditor for the annual accounts and the EU IFRS consolidated accounts of the Company for the financial year ending on December 31, 2025;
8.Appointment of Price Waterhouse & Co. S.R.L. as independent auditor for the IFRS consolidated accounts of the Company for the financial year ending on December 31, 2025;
9.Re-appointment of Mrs. María Pinelli as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2028;
10.Re-appointment of Ms. Andrea Mayumi Petroni Merhy as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2028;
11.Re-appointment of Mr. Francisco álvarez-Demalde as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2028;
|
| 2025-02-28 |
详情>>
股本变动：
变动后总股本4404.56万股
|
| 2025-02-28 |
详情>>
业绩披露：
2022年年报每股收益3.55美元,归母净利润1.49亿美元,同比去年增长54.99%
|
| 2025-02-28 |
详情>>
业绩披露：
2024年年报每股收益3.82美元,归母净利润1.66亿美元,同比去年增长4.54%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益2.94美元,归母净利润1.27亿美元,同比去年增长9.38%
|
| 2024-08-15 |
详情>>
业绩披露：
2024年中报每股收益1.94美元,归母净利润8371.80万美元,同比去年增长14.04%
|
| 2024-05-16 |
详情>>
业绩披露：
2024年一季报每股收益1.05美元,归母净利润4506.00万美元,同比去年增长23.73%
|
| 2024-04-09 |
股东大会：
将于2024-05-10召开股东大会
会议内容 ▼▲
- 1.Presentation of the reports of the independent auditor and of the reports of the Board of Directors of the Company on the consolidated accounts for the financial year ended on December 31, 2023 and on the annual accounts of the Company for the financial year ended on December 31, 2023.
2.Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the financial year ended December 31, 2023.
3.Approval of the Company’s annual accounts under LUX GAAP as of and for the financial year ended December 31, 2023.
4.Allocation of results for the financial year ended December 31, 2023.
5.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2023.
6.Approval and ratification of the share-based compensation granted to a certain non-executive member of the Board of Directors during the financial year ending on December 31, 2023.
7.Approval of the cash and share-based compensation payable to the non-executive members of the Board of Directors for the financial year ending on December 31, 2024.
8.Appointment of PricewaterhouseCoopers, Société coopérative, as independent auditor for the annual accounts and the EU IFRS consolidated accounts of the Company for the financial year ending on December 31, 2024.
9.Appointment of Price Waterhouse & Co. S.R.L. as independent auditor for the IFRS consolidated accounts of the Company for the financial year ending on December 31, 2024.
10.Re-appointment of Mr. Martín Migoya as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2027.
11.Appointment of Mr. Andrew McLaughlin as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2027.
12.Appointment of Mr. Alejandro Nicolás Aguzin as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2027.
13.Renewal of the authorization granted to the Board of Directors, according to article 430-15 of the law of 10 August 1915 on commercial companies, as amended, to repurchase during a five-year period ending on the fifth (5th) anniversary of this Annual General Meeting of Shareholders, a maximum number of common shares representing twenty percent (20%) of the issued share capital of the Company, for a net purchase price that is (i) no less than fifty percent (50%) of the lowest common share price and (ii) no more than fifty percent (50%) above the highest common share price, in each case, such common share price being the closing price reported by the New York City edition of the Wall Street Journal, or, if not reported therein, any other authoritative source to be selected by the Board of Directors, over the ten (10) trading days preceding the date of the purchase (or as the case may be, the date of the commitment to the transaction).
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益3.72美元,归母净利润1.59亿美元,同比去年增长6.48%
|
| 2023-11-16 |
详情>>
业绩披露：
2023年三季报(累计)每股收益2.74美元,归母净利润1.16亿美元,同比去年增长6.11%
|
| 2023-03-14 |
股东大会：
将于2023-04-19召开股东大会
会议内容 ▼▲
- 1. Presentation of the reports of the independent auditor and of the reports of the Board of Directors of the Company on the consolidated accounts for the financial year ended on December 31, 2022 and on the annual accounts of the Company for the financial year ended on December 31, 2022.
2. Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the financial year ended December 31, 2022.
3. Approval of the Company’s annual accounts under LUX GAAP as of and for the financial year ended December 31, 2022.
4. Allocation of results for the financial year ended December 31, 2022.
5. Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2022.
6. Approval of the cash and share based compensation payable to the non-executive members of the Board of Directors for the financial year ending on December 31, 2023.
7. Appointment of PricewaterhouseCoopers, Société coopérative, as independent auditor for the annual accounts and the EU IFRS consolidated accounts of the Company for the financial year ending on December 31, 2023.
8. Appointment of Price Waterhouse & Co. S.R.L. as independent auditor for the IFRS consolidated accounts of the Company for the financial year ending on December 31, 2023.
9. Re-appointment of Mrs. Linda Rottenberg as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2026.
10. Re-appointment of Mr. Martín Umaran as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2026.
11. Re-appointment of Mr. Guibert Englebienne as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2026.
|
| 2022-03-31 |
复牌提示：
2022-03-30 10:16:20 停牌，复牌日期 2022-03-30 12:33:45
|
| 2022-03-15 |
股东大会：
将于2022-04-22召开股东大会
会议内容 ▼▲
- 1. Presentation of the reports of the independent auditor and of the reports of the Board of Directors of the Company on the consolidated accounts for the financial year ended on December 31, 2021 and on the annual accounts of the Company for the financial year ended on December 31, 2021.
2. Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the financial year ended December 31, 2021.
3. Approval of the Company’s annual accounts under LUX GAAP as of and for the financial year ended December 31, 2021.
4. Allocation of results for the financial year ended December 31, 2021.
5. Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2021.
6. Approval of the cash and share based compensation payable to the non-executive members of the Board of Directors for the financial year ending on December 31, 2022.
7. Appointment of PricewaterhouseCoopers, Société coopérative as independent auditor for the annual accounts and the EU IFRS consolidated accounts of the Company for the financial year ending on December 31, 2022.
8. Appointment of Price Waterhouse & Co. S.R.L. as independent auditor for the IFRS consolidated accounts of the Company for the financial year ending on December 31, 2022.
9. Re-appointment of Mr. Francisco álvarez-Demalde as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2025.
10. Re-appointment of Ms. Maria Pinelli as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2025.
11. Appointment of Ms. Andrea Mayumi Petroni Merhy as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2025.
12. Decision to increase the authorized capital of the Company, excluding the Company's share capital, to the amount of four million eight hundred two thousand and twenty US dollars and eighty cents (USD 4,802,020.80), represented by four million one thousand six hundred and eighty four (4,001,684) common shares having a nominal value of one US dollar and twenty cents (USD 1.20) each, including authorization of the Board of Directors to waive, suppress or limit any pre-emptive subscription rights of existing shareholders for any issue or issues of common shares within the scope of the Company’s authorized capital during a period of five (5) years starting from the date of the Extraordinary General Meeting of Shareholders, and subsequent amendment of articles 6.1 and 6.2 of the articles of association.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-03 |
股东大会：
将于2021-04-02召开股东大会
会议内容 ▼▲
- 1.Presentation of the reports of the independent auditor and of the reports of the Board of Directors of the Company on the consolidated accounts for the financial year ended on December 31, 2020 and on the annual accounts of the Company for the financial year ended on December 31, 2020.
2.Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the financial year ended December 31, 2020.
3.Approval of the Company’s annual accounts under LUX GAAP as of and for the financial year ended December 31, 2020.
4.Allocation of results for the financial year ended December 31, 2020.
5.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended on December 31, 2020.
6.Approval of the cash and share based compensation payable to the non-executive members of the Board of Directors for the financial year ending on December 31, 2021.
|
| 2020-03-10 |
股东大会：
将于2020-04-03召开股东大会
会议内容 ▼▲
- 1.Presentation of the reports of the independent auditor and of the reports of the Board of Directors of the Company on the consolidated accounts for the financial year ended on December 31, 2019 and on the annual accounts of the Company for the financial year ended on December 31, 2019.
2.Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the financial year ended December 31, 2019.
3.Approval of the Company’s annual accounts under LUX GAAP as of and for the financial year ended December 31, 2019.
4.Allocation of results for the financial year ended December 31, 2019.
5.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2019.
6.Approval of the cash and share based compensation payable to the non-executive members of the Board of Directors for the financial year ending on December 31, 2020.
7.Appointment of PricewaterhouseCoopers, Societe cooperative as independent auditor for the annual accounts and the EU IFRS consolidated accounts of the Company for the financial year ending on December 31, 2020.
8.Appointment of Price Waterhouse & Co. S.R.L. as independent auditor for the IFRS consolidated accounts of the Company for the financial year ending on December 31, 2020.
9.Re-appointment of Mr. Martin Gonzalo Umaran as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2023.
10.Re-appointment of Mr. Guibert Andres Englebienne as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2023.
11.Re-appointment of Mrs. Linda Rottenberg as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2023.
|
| 2019-04-30 |
股东大会：
将于2019-05-31召开股东大会
会议内容 ▼▲
- 1.Presentation of the reports of the independent auditor and of the reports of the Board of Directors of the Company on the consolidated accounts for the financial year ended on December 31, 2018 and on the annual accounts of the Company for the financial year ended on December 31, 2018.
2.Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the financial year ended December 31, 2018.
3.Approval of the Company’s annual accounts under LUX GAAP as of and for the financial year ended December 31, 2018.
4.Allocation of results for the financial year ended December 31, 2018.
5.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2018.
6.Approval and ratification of the equity awards granted to certain non-executive members of the Board of Directors during the financial year ended on December 31, 2018.
7.Approval of the cash compensation payable to the non-executive members of the Board of Directors for the financial year ending on December 31, 2019.
8.Approval of the share based compensation payable to certain non-executive members of the Board of Directors for the financial year ending on December 31, 2019.
9.Appointment of Deloitte Audit as independent auditor for the annual accounts and the EU IFRS consolidated accounts of the Company for the financial year ending on December 31, 2019.
10.Appointment of Deloitte & Co S.A. as independent auditor for the IFRS consolidated accounts of the Company for the financial year ending December 31, 2019.
11.Re-appointment of Mr. Mario Vazquez as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2022.
12.Re-appointment of Mr. Francisco álvarez-Demalde as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2022.
13.Re-appointment of Mr. Marcos Galperin as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2022.
14.Appointment of Mr. Richard Haythornthwaite as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2021.
15.Renewal of the authorization granted to the Board of Directors, according to article 430-15 of the law of 10 August 1915 on commercial companies, as amended, to repurchase during a five-year period ending on the fifth anniversary of this Annual General Meeting of Shareholders, a maximum number of common shares representing twenty percent (20%) of the issued share capital of the Company for a net purchase price that is (i) no less than fifty percent (50%) of the lowest common share price and (ii) no more than fifty percent (50%) above the highest common share price, in each case, such common share price being the closing price reported by the New York City edition of the Wall Street Journal, or, if not reported therein, any other authoritative source to be selected by the Board of Directors, over the ten (10) trading days preceding the date of the purchase (or as the case may be the date of the commitment to the transaction).
|
| 2018-05-18 |
股东大会：
将于2018-06-20召开股东大会
会议内容 ▼▲
- 1.Presentation of the reports of the independent auditor and of the reports of the Board of Directors of the Company on the consolidated accounts for the financial year ended on December 31, 2017 and on the annual accounts of the Company for the financial year ended on December 31, 2017.
2.Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the financial year ended December 31, 2017.
3.Approval of the Company’s annual accounts under LUX GAAP as of and for the financial year ended December 31, 2017.
4.Allocation of results for the financial year ended December 31, 2017.
5.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2017.
6.Approval and ratification of the restricted stock units granted to the members of the Board of Directors during the financial year ended on December 31, 2017.
7.Approval of the cash compensation of the members of the Board of Directors for the financial year ending on December, 31 2018.
8.Appointment of Deloitte Audit as independent auditor for the annual accounts and the EU IFRS Consolidated Accounts of the Company for the financial year ending on December 31, 2018.
9.Appointment of Deloitte & Co S.A. as independent auditor for the IFRS consolidated accounts of the Company for the financial year ending December 31, 2018.
10.Re-appointment of Mr. Martín Migoya as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2021.
11.Re-appointment of Mr. David J. Moore as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2021.
12.Re-appointment of Mr. Philip A. Odeen as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2021.
|
| 2017-04-07 |
股东大会：
将于2017-05-08召开股东大会
会议内容 ▼▲
- 1. Acknowledgement of the postponement of the date of the Annual General Meeting.
2. Presentation of the reports of the independent auditor and of the reports of the Board of Directors of the Company on the consolidated accounts as of and for the financial year ended on December 31, 2016 and on the annual accounts of the Company for the financial year ended on December 31, 2016.
3. Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the financial year ended December 31, 2016.
4. Approval of the Company’s annual accounts under LUX GAAP as of and for the financial year ended December 31, 2016.
5. Allocation of results for the financial year ended December 31, 2016.
6. Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2016.
7. Approval and ratification of the stock options granted to the members of the Board of Directors during the financial year ended on December 31, 2016.
8. Approval of the cash compensation of the members of the Board of Directors for the financial year ending on December, 31 2017.
9. Appointment of Deloitte Audit as independent auditor for the annual accounts and the EU IFRS Consolidated Accounts of the Company for the financial year ending on December 31, 2017.
10. Appointment of Deloitte & Co S.A. as independent auditor for the IFRS consolidated accounts of the Company for the financial year ending December 31, 2017.
11. Appointment of Mrs. Linda Rottenberg as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2020.
12. Re-appointment of Mr. Martín Gonzalo Umaran as member of the board of directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2020.
13. Re-appointment of Mr. Guibert Andres Englebienne as member of the board of directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2020.
|
| 2016-04-13 |
股东大会：
将于2016-05-06召开股东大会
|
| 2015-04-16 |
股东大会：
将于2015-05-04召开股东大会
会议内容 ▼▲
- 1. Acknowledgement of the postponement of the date of the Annual General Meeting.
2. Presentation of the reports of the independent auditor and of the reports of board of directors of the Company on the consolidated accounts for the financial year ended on December 31, 2013 and December 31, 2014 and on the annual accounts of the Company for the financial year ended on December 31, 2014.
3. Approval of the consolidated accounts of the Company prepared under EU IFRS as of and for the year ended December 31, 2013.
4. Approval of the consolidated accounts of the Company prepared under EU IFRS and IFRS as of and for the year ended December 31, 2014.
5. Approval of the Company’s annual accounts under LUX GAAP as of December 31, 2014.
6. Allocation of results for the financial year ended December 31, 2014.
7. Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2014.
8. Approval and ratification of the excess compensation of the members of the Board of Directors for the financial year ended on 31 December 2014.
9. Approval of the compensation of the members of the Board of Directors for the financial year ending on 31 December 2015.
10. Appointment of Deloitte Audit as independent auditor for the annual accounts of the Company for the financial year ending on December 31, 2015.
11. Appointment of Deloitte & Co S.A. as independent auditor for the consolidated accounts of the Company for the financial year ending on December 31, 2015.
12. Renewal of the mandate of Mr. Francisco Alvarez-Demalde as member of the board of directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2018.
13. Renewal of the mandate of Mr. Bradford Eric Bernstein as member of the board of directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2018.
14. Renewal of the mandate of Mr. Philip Odeen as member of the board of directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2018.
15. Appointment of Mr. David J. Moore as member of the board of directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2018.
|